Sears Capital Management

Total investments

9

Average round size

13M

Portfolio companies

5

Rounds per year

0.31

Lead investments

1

Follow on index

0.33

Exits

3

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalNeurosciencePharmaceuticalTherapeuticsBiopharma

Summary

Sears Capital Management is the famous VC, which was founded in 1994. The main department of described VC is located in the Cupertino. The fund was located in North America if to be more exact in United States.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Sears Capital Management, startups are often financed by Asset Management Company, BioBrit, Vivo Capital. The meaningful sponsors for the fund in investment in the same round are BioBrit, Vivo Capital, Sofinnova Investments. In the next rounds fund is usually obtained by Asset Management Company, VentureSouth, OrbiMed.

Besides them, we counted 1 critical employee of this fund in our database.

Opposing the other organizations, this Sears Capital Management works on 0 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2013. The top amount of exits for fund were in 2014. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Among the most successful fund investment fields, there are Medical, Biopharma. Among the various public portfolio startups of the fund, we may underline CharlestonPharma,LLC, SiteOne Therapeutics, Peninsula Pharmaceuticals The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
9
Lead investments
1
Exits
3
Rounds per year
0.31
Follow on index
0.33
Investments by industry
  • Biotechnology (7)
  • Therapeutics (5)
  • Medical (5)
  • Health Diagnostics (4)
  • Health Care (3)
  • Show 4 more
Investments by region
  • United States (8)
Peak activity year
2008

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
15
Avg. valuation at time of investment
50M
Group Appearance index
0.89
Avg. company exit year
6
Avg. multiplicator
1.71

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
SiteOne Therapeutics 06 Jan 2017 Biotechnology, Health Diagnostics, Medical, Therapeutics Early Stage Venture 15M United States, Montana, Bozeman
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.